BioStock: The five best life science stocks of the first half-year

July 5, 2023
Language flag

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.

This great acknowledgment comes from Biostock, Scandinavia’s leading digital news and analysis service for the Life Science sector. PHI’s performance has been recognized alongside the life science companies Prolight Diagnostics, Saniona, Lipidor, and Ziccum.

Our team is honored to feature on this top list. And we remain committed to advancing our innovative solutions for non-invasive cell analysis and quality control in regenerative medicine.

Read the full article on biostock.se.

Latest News

Phase Holographic Imaging PHI AB Announces Intent to File for Bankruptcy

Phase Holographic Imaging PHI AB (PHI), a pioneer in advanced holographic imaging solutions for life sciences, today announces its intention to file for bankruptcy with the Swedish District Court on January 12, 2026.
IMG_4821

Interim Report 2 2025/26

The first quarter of the fiscal year marks a pivotal moment for PHI as we continue to build momentum across our strategic pillars. Our commitment to innovation, clinical integration, and global expansion remains steadfast, and the progress made this quarter reflects the dedication and ingenuity of our entire team.
Schematic, blue image of an egg cell held by a pipette.

Biostock: PHI comments on expansion into veterinary IVF

Phase Holographic Imaging is broadening its focus. The company, which previously operated in regenerative medicine and cell therapy, is now adding the fast-growing field of in vitro fertilization, IVF, for livestock to its pipeline. BioStock contacted CEO Patrik Eschricht to learn more about the decision and what opportunities he sees with the new venture.
See All News